Insmed (INSM) Free Cash Flow (2010 - 2026)

Insmed has reported Free Cash Flow for 17 years, with the latest figure at -$95.1 million in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 58.53% year-over-year to -$95.1 million in Q2 2026; TTM through Jun 2026 was -$807.7 million, a 9.83% increase from a year earlier, with the FY2025 full-year figure at -$967.6 million, down 37.09% from the prior year.
• Free Cash Flow was -$95.1 million for Q2 2026 at Insmed, up from -$226.2 million in the prior quarter.
• The five-year high for Free Cash Flow was -$87.3 million in Q3 2022, with the low at -$264.2 million in Q4 2025.
• Average Free Cash Flow over 5 years is -$165.4 million, with a median of -$148.2 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Free Cash Flow plunged 123.54% in 2025, then soared 58.53% in 2026.
• Over 5 years, Free Cash Flow stood at -$115.4 million in 2022, then dropped by 16.14% to -$134.0 million in 2023, then slumped by 51.32% to -$202.8 million in 2024, then slumped by 30.3% to -$264.2 million in 2025, then jumped by 64.01% to -$95.1 million in 2026.
• The last three Free Cash Flow figures came in at -$95.1 million (Q2 2026), -$226.2 million (Q1 2026), and -$264.2 million (Q4 2025), per Business Quant data.